SRB Corp’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,636
Closed -$538K 87
2023
Q4
$538K Buy
6,636
+469
+8% +$36.5K 0.03% 52
2023
Q3
$462K Buy
6,167
+579
+10% +$44.5K 0.03% 50
2023
Q2
$431K Buy
5,588
+1,328
+31% +$106K 0.03% 83
2023
Q1
$353K Buy
+4,260
New +$353K 0.02% 70
2022
Q4
Sell
-6,558
Closed -$404K 103
2022
Q3
$404K Sell
6,558
-17,081
-72% -$1.08M 0.03% 35
2022
Q2
$1.46M Buy
23,639
+2,936
+14% +$182K 0.09% 45
2022
Q1
$1.23M Hold
20,703
0.07% 84
2021
Q4
$1.5M Sell
20,703
-2,883
-12% -$199K 0.08% 26
2021
Q3
$1.65M Buy
+23,586
New +$1.66M 0.1% 33
2020
Q3
Sell
-6,634
Closed -$510K 158
2020
Q2
$510K Sell
6,634
-1,298
-16% -$99.5K 0.04% 95
2020
Q1
$593K Buy
+7,932
New +$548K 0.06% 15
2019
Q4
Sell
-7,123
Closed -$451K 155
2019
Q3
$451K Sell
7,123
-311
-4% -$20.3K 0.04% 138
2019
Q2
$502K Buy
+7,434
New +$489K 0.05% 93
2015
Q4
Sell
-1,414
Closed -$138K 152
2015
Q3
$138K Buy
1,414
+99
+8% +$11K 0.02% 154
2015
Q2
$154K Sell
1,315
-306
-19% -$33.4K 0.02% 24
2015
Q1
$159K Buy
+1,621
New +$165K 0.02% 130

Other funds holding GILD

SRB Corp's GILD Position: Q1 2024 in Review

SRB Corp sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 6,636 shares — an estimated $538K sold.

SRB Corp first reported a position in GILD in Q1 2015 and held it in 16 quarters. The position peaked at $1.65M in Q3 2021. 1,722 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • SRB Corp reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • SRB Corp sold 6,636 Gilead Sciences shares in Q1 2024, an estimated $538K.
  • SRB Corp first reported a position in Gilead Sciences in Q1 2015 and held it in 16 quarters.
  • SRB Corp's Gilead Sciences position peaked at $1.65M in Q3 2021.
  • 1,722 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on SRB Corp's 13F filing for Q1 2024, filed 14 May 2024.